← FDA DRUG APPROVALS

FDA ANDA · ANDA089538

MEPROBAMATE

Sponsor: LEE KM

APPLICATION
ANDA089538
TYPE
ANDA
ORIGINAL APPROVAL
1987-11-25
LATEST ACTION
1989-01-04
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

MEPROBAMATEDiscontinued
MEPROBAMATE 400MG · TABLET · ORAL

Approval history

1989-01-04Labeling · Supplement 2AP
1987-11-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →